Loading...

Home
Stock
QURE

QURE News & Events

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Stock Price Prediction Technical Valuation Financials Earnings Should I Buy News & Events

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press
Privacy
Terms of Service
Service Terms of Use

Resources

Blog
Tutorial
Help Center
Affiliate Program

Markets

Market Analysis
Crypto
Featured Screeners
AI Earnings Calendar
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

QuantAI Alpha Pick
SwingMax Portfolio
Swing Trading
AI Stock Picker
Whales Auto Tracker
Daytrading Center
Patterns Detection
AI Screener
Financial AI Agent
Backtesting Playground
AI Earnings Prediction
Stock Monitor
Technical Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

QURE News

FDA's Regulatory Reversal Boosts Biotech Sector

Jun 24 2026seekingalpha

uniQure Prices Public Offering at $225 Million

Jun 24 2026seekingalpha

uniQure N.V. Upsizes Public Offering to $225 Million

Jun 24 2026NASDAQ.COM

uniQure Prices Public Offering at $45.50 per Share, Raising $225 Million

Jun 24 2026Newsfilter

uniQure Proposes $150 Million Public Offering to Strengthen Balance Sheet

Jun 23 2026NASDAQ.COM

uniQure Launches $150M Underwritten Public Offering

Jun 22 2026seekingalpha

uniQure Achieves Major Regulatory Milestone for Gene Therapy

Jun 19 2026NASDAQ.COM

uniQure Releases Initial Data on Gene Therapy AMT-260

Jun 19 2026Newsfilter

QURE Events

Deal Size Increased to $225M

The deal size was increased to $225M from $150M and priced below the last closing price of $49.04 per share. Leerink and Stifel are acting as joint book running managers for the offering.

uniQure Stock Rises 7.6% to $47.74

uniQure is up 7.6%, or $3.35 to $47.74.

QURE Monitor News

uniQure plans to submit BLA for AMT-130 in Huntington's disease

uniQure NV stock rises after crossing above key SMA

uniQure Reports Strong Q1 Growth Amid Regulatory Updates

uniQure Faces Class Action Lawsuit Amid Investor Losses

uniQure Faces Class Action Lawsuit Amid FDA Scrutiny

uniQure faces class action lawsuit amid FDA concerns

uniQure Faces Class Action Lawsuit Over FDA Approval Issues

uniQure Faces Class Action Lawsuit Over AMT-130 Misrepresentation

QURE Earnings Analysis

No Data

No Data

People Also Watch